The Department of Health and Social Care (DHSC) has warned that Diamorphine 5mg injections and contraceptive tablets Microgynon 30 and Ovranette could go out of stock from late May.
In a letter, dated May 21, Sarah McAleer, principal pharmacist on the department’s medical supply team said Accord and Wockhardt are experiencing issues with the manufacture and availability of Diamorphine 5mg injections. There is an anticipated out of stock period between May 27 and early August.
Microgynon 30 and Ovranette tablets, manufactured by Bayer and Pfizer respectively, will also go out of stock as the firms are facing capacity constraints.
Microgynon 30 could go out of stock from late May till mid July and Ovranette tablets, from early June to August.
McAleer assured enough supplies of Diamorphine 10mg injections to support forecasted use of diamorphine 5mg injection for primary care including hospices. She suggested prescribers to switch to alternative suppliers for ethinylestradiol 30mg/levonorgestrel 150mg tablets.